Carregant...
Structure-based design of altered MHC II-restricted peptide ligands with heterogeneous immunogenicity()
Insights gained from characterizing MHC-peptide-TCR interactions have held the promise that directed structural modifications can have predictable functional consequences. The ability to manipulate T cell reactivity synthetically or through genetic engineering might thus be translated into new thera...
Guardat en:
| Autors principals: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3888030/ https://ncbi.nlm.nih.gov/pubmed/24108701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1300467 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|